Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic effect of favipiravir in COVID-19 patients
IRCT20211004052664N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20211004052664N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211004052664N1.